U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1818118181An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)RecruitingNo Results AvailablePsoriasis|Plaque PsoriasisBiological: Certolizumab Pegol|Other: Placebohttps://ClinicalTrials.gov/show/NCT02326298
1818218182Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIBNot yet recruitingNo Results AvailableNon-squamous Non-small Cell Lung Cancer Stage II|Non-squamous Non-small Cell Lung Cancer Stage IIIA|Non-squamous Non-small Cell Lung Cancer Stage IIIB|Activating EGFR Mutation|NSCLCDrug: Gefitinib|Drug: docetaxel|Drug: cisplatin|Procedure: Surgeryhttps://ClinicalTrials.gov/show/NCT02326285
1818318183A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)RecruitingNo Results AvailablePsoriasis|Plaque PsoriasisBiological: Certolizumab Pegol|Other: Placebohttps://ClinicalTrials.gov/show/NCT02326272
1818418184Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of HyperglycemiaRecruitingNo Results AvailableDiabetic RetinopathyOther: Initiation of treatment of diabeteshttps://ClinicalTrials.gov/show/NCT02326259
1818518185MRI in Active Surveillance of Prostate CancerRecruitingNo Results AvailableProstate CancerOther: multi-parametic MRIhttps://ClinicalTrials.gov/show/NCT02326246
1818618186Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy SubjectsNot yet recruitingNo Results AvailableHealthyBiological: Pen of SB5|Biological: PFS of SB5https://ClinicalTrials.gov/show/NCT02326233
1818718187Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis TherapyRecruitingNo Results AvailableHeterozygous Familial HypercholesterolemiaDrug: Alirocumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02326220
1818818188Weekly Versus no Routine Ventilator Circuit Changes in NICURecruitingNo Results AvailablePneumonia, Ventilator-AssociatedDevice: Infant Ventilator Circuit Dual Heated with Autofeed Chamberhttps://ClinicalTrials.gov/show/NCT02326207
1818918189A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.CompletedNo Results AvailableEbola Virus DiseaseBiological: Low dose Ebola Zaire vaccine (Ad5-EBOV)|Biological: High dose Ebola Zaire vaccine (Ad5-EBOV)|Biological: placebo (one dose)|Biological: placebo (two doses)https://ClinicalTrials.gov/show/NCT02326194
1819018190Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary DiseaseNot yet recruitingNo Results AvailableChronic Obstructive Pulmonary Disease(COPD)Device: inspiratory pressure training group|Device: mixed training grouphttps://ClinicalTrials.gov/show/NCT02326181
1819118191PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder CancerActive, not recruitingNo Results AvailableBladder CancerDrug: Bacillus Calmette-Guerin (BCG)https://ClinicalTrials.gov/show/NCT02326168
1819218192To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)RecruitingNo Results AvailableCrohn's Disease|Ulcerative Colitishttps://ClinicalTrials.gov/show/NCT02326155
1819318193A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm BirthRecruitingNo Results AvailablePreterm LaborDrug: OBE001|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02326142
1819418194Novel Biomarker for Development of T2DNot yet recruitingNo Results AvailableDiabetes Type IIhttps://ClinicalTrials.gov/show/NCT02326129
1819518195TTE and Dysphagia in Anterior Cervical SurgeryRecruitingNo Results AvailableDysphagiaOther: Trachael Preparation Educationhttps://ClinicalTrials.gov/show/NCT02326116
1819618196Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic HepatitisRecruitingNo Results AvailableAlcoholic Hepatitis|Alcoholic CirrhosisDrug: Ciprofloxacin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02326103
1819718197Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry EyeCompletedNo Results AvailableDry Eye SyndromeDrug: cis-UCA ophthalmic solution 1.0%|Drug: cis-UCA ophthalmic solution 2.5%|Drug: Placebo ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT02326090
1819818198Sonopartogram. The Next Step in the Delivery RoomRecruitingNo Results AvailableNormal Labor|Obstetric Labor ComplicationsOther: Ultrasoundhttps://ClinicalTrials.gov/show/NCT02326077
1819918199Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4RecruitingNo Results AvailableOvarian Tumor|Ovarian Cancerhttps://ClinicalTrials.gov/show/NCT02326064
1820018200Timing of Initiation of LMWH Administration in Pregnant Women With APSRecruitingNo Results AvailableRecurrent Miscarriage|Antiphospholipid SyndromeDrug: Enoxaparin|Drug: Enoxaparinhttps://ClinicalTrials.gov/show/NCT02326051
1820118201Ritalin, Memory and Attention in MCI: a Behaviour-EEG StudyRecruitingNo Results AvailableMild Cognitive ImpairmentDrug: Methylphenidatehttps://ClinicalTrials.gov/show/NCT02326038
1820218202A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue SarcomaActive, not recruitingNo Results AvailableSarcoma, Soft TissueDrug: Olaratumab|Drug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT02326025
1820318203Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot StudyRecruitingNo Results AvailableNonsuicidal Self-InjuryBehavioral: Emotion Regulation Individual Therapy for Adolescentshttps://ClinicalTrials.gov/show/NCT02326012
1820418204Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric CancerRecruitingNo Results AvailableEarly Gastric CancerProcedure: ESD AND LRLDhttps://ClinicalTrials.gov/show/NCT02325999
1820518205Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal CancerNot yet recruitingNo Results AvailableEsophageal Squamous Cell CarcinomaDrug: fluorouracil|Drug: Cisplatin|Radiation: Intensity-modulated radiation therapyhttps://ClinicalTrials.gov/show/NCT02325986
1820618206Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCIRecruitingNo Results AvailableMulti Vessel Coronary Artery Disease|STEMIDevice: PressureWire Certus guidewirehttps://ClinicalTrials.gov/show/NCT02325973
1820718207A Comparison of Exenatide and Insulin Glargine on Glycemic Variability in Type 2 Diabetes Patients Inadequately Controlled With Metformin MonotherapyNot yet recruitingNo Results AvailableType 2 DiabetesDrug: exenatide|Drug: Insulin glarginehttps://ClinicalTrials.gov/show/NCT02325960
1820818208Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke PatientsNot yet recruitingNo Results AvailablePoststroke/CVA ParesisDevice: hand exoskeleton, brain-computer interface (BCI),|Device: hand exoskeleton, sham BCIhttps://ClinicalTrials.gov/show/NCT02325947
1820918209Bioequivalence of Crushed Stribild With a Normal Breakfast or With Drip Feed Compared to the Whole TabletCompletedNo Results AvailableHIVDrug: Stribild|Drug: Stribild, crushedhttps://ClinicalTrials.gov/show/NCT02325934
1821018210MRI in Renal TumorsRecruitingNo Results AvailableRenal Cell CarcinomaDevice: Magnetic Resonance Imaginghttps://ClinicalTrials.gov/show/NCT02325921

* Görseller ve İçerik tekif hakkına sahip olabilir